Skip to content

Clinical trials

Severe Acute Respiratory Syndrome trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Severe Acute Respiratory Syndrome Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
202010
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
VBI Vaccines Inc.2
Arch Biopartners Inc.1
AstraZeneca1
GlaxoSmithKline1
Hôpital de Verdun1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
National Institute of Allergy and Infectious Diseases (NIAID)1
Population Health Research Institute1
Queen's University1
University of Alberta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Severe Acute Respiratory Syndrome14
COVID-1912
Coronavirus Infections11
Respiratory Distress Syndrome5
Acute Kidney Injury2
Lung Diseases2
Virus Diseases2
Coronaviridae Infections1
Infections1
Influenza, Human1

Trials

Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.